Zhejiang Medicine Co., Ltd. (SHA:600216)

Zhejiang Medicine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,217	1,966	1,460	1,438	1,769	1,629
Short-Term Investments	-	-	-	-	2.9	50
Trading Asset Securities	290.71	294.91	328.31	447.29	454.4	270.73
Cash & Short-Term Investments	2,508	2,261	1,788	1,885	2,226	1,950
Cash Growth	34.01%	26.41%	-5.15%	-15.30%	14.17%	10.91%
Accounts Receivable	1,966	1,830	1,419	1,501	1,594	1,402
Other Receivables	76.07	194.79	239.14	67.35	105.17	141.38
Receivables	2,042	2,025	1,658	1,568	1,699	1,544
Inventory	2,040	2,133	2,011	1,995	1,873	1,480
Prepaid Expenses	-	-	-	0.03	0.36	0.9
Other Current Assets	222.14	166.46	143.88	207.17	236.04	143.85
Total Current Assets	6,812	6,585	5,601	5,655	6,035	5,118
Property, Plant & Equipment	6,097	6,121	6,019	5,618	5,360	4,513
Long-Term Investments	144.3	156.51	166.21	144.51	126.07	195.48
Goodwill	-	-	18.68	27.91	36.03	-
Other Intangible Assets	664.01	684.4	744.3	747.68	728.81	409.75
Long-Term Deferred Tax Assets	139.4	124.94	82.12	77.41	78.8	86.49
Long-Term Deferred Charges	11.72	12.81	6.22	8.85	0.41	27.18
Other Long-Term Assets	128.73	110.66	141.15	153.27	167.76	150.18
Total Assets	13,997	13,795	12,780	12,433	12,532	10,500
Accounts Payable	1,067	1,130	744.03	702.48	897.83	504.75
Accrued Expenses	88.99	213.87	253.95	263.98	287.32	534.42
Short-Term Debt	270.27	270.28	231.41	82.25	225.33	250.31
Current Portion of Long-Term Debt	380	306.86	370.37	550.64	-	200.17
Current Portion of Leases	-	-	0.3	0.28	-	-
Current Income Taxes Payable	182.75	268.26	11.88	21.75	153.51	95.69
Current Unearned Revenue	38.58	29.31	43.95	61.88	53.81	54.6
Other Current Liabilities	359.03	351.09	822.53	782.11	1,407	284.22
Total Current Liabilities	2,387	2,569	2,478	2,465	3,025	1,924
Long-Term Debt	146.13	171.15	230.22	200.19	250.34	500.65
Long-Term Leases	0.3	0.14	0.32	0.62	1.16	-
Long-Term Unearned Revenue	115.58	104.6	84.16	54.11	53.08	34.24
Long-Term Deferred Tax Liabilities	-	-	-	2.47	21.12	11.38
Other Long-Term Liabilities	81.74	82.2	-	-	-	-
Total Liabilities	2,731	2,928	2,793	2,723	3,350	2,470
Common Stock	961.64	961.64	964.98	965.13	965.13	965.13
Additional Paid-In Capital	1,990	1,988	2,005	1,941	1,692	1,398
Retained Earnings	8,109	7,700	6,682	6,417	6,195	5,371
Treasury Stock	-	-	-27.63	-57.69	-59.98	-59.98
Comprehensive Income & Other	7.21	-1.36	5.77	-5.27	-13.99	0.41
Total Common Equity	11,068	10,648	9,631	9,260	8,779	7,675
Minority Interest	198.16	219.8	355.68	449.98	402.93	355.48
Shareholders' Equity	11,266	10,868	9,986	9,710	9,182	8,030
Total Liabilities & Equity	13,997	13,795	12,780	12,433	12,532	10,500
Total Debt	796.7	748.43	832.63	833.97	476.82	951.12
Net Cash (Debt)	1,711	1,512	955.7	1,051	1,749	998.53
Net Cash Growth	67.77%	58.24%	-9.10%	-39.89%	75.16%	-9.87%
Net Cash Per Share	1.81	1.58	0.99	1.09	1.82	1.04
Filing Date Shares Outstanding	951.36	939.86	925.92	958.3	958.3	958.3
Total Common Shares Outstanding	951.36	939.86	925.92	958.3	958.3	958.3
Working Capital	4,425	4,015	3,123	3,190	3,010	3,194
Book Value Per Share	11.63	11.33	10.40	9.66	9.16	8.01
Tangible Book Value	10,404	9,964	8,868	8,484	8,014	7,265
Tangible Book Value Per Share	10.94	10.60	9.58	8.85	8.36	7.58
Buildings	-	-	2,919	2,812	2,509	2,171
Machinery	-	-	6,897	6,158	5,366	4,839
Construction In Progress	-	-	931.69	825.71	1,119	638.83

Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.